# Patient-Trial Match Report

*Generated: 2026-01-05 18:32:43*

## Patient Profile

- **Age**: 28
- **Sex**: Female
- **Cancer Type**: synovial sarcoma
- **Biomarkers**: SS18-SSX fusion

**Clinical Description**:
> 28-year-old female with newly diagnosed metastatic synovial sarcoma. Primary tumor in right thigh (12cm) with pulmonary metastases identified on staging workup. Biopsy confirmed synovial sarcoma with SS18-SSX1 fusion by FISH. No prior systemic therapy - seeking first-line clinical trial options vs standard doxorubicin/ifosfamide. Young, athletic, highly motivated patient. Recently married, no children, interested in fertility preservation options. Comprehensive molecular profiling pending. No significant medical history. All labs normal.

- **Location Preference**: United States

## Search Summary

- **Search terms used**: 11
- **Total trials evaluated**: 100
- **Excluded by fast filter**: 93
- **LLM scored**: 7

## üü¢ HIGH Likelihood (2 trials)

### [NCT05910307](https://clinicaltrials.gov/study/NCT05910307)

**Synovial Sarcoma Registry and Biospecimen Repository**

- **Sponsor**: Children's Hospital of Philadelphia
- **Phase**: N/A
- **Status**: Recruiting
- **Confidence**: 85%

**‚úì Supporting Factors:**
- Patient has a reported diagnosis of synovial sarcoma
- Patient is treatment-naive (no prior systemic therapy)
- Patient is aged 28, which meets the age requirement
- Patient has an ECOG status of 0
- Patient has no brain metastases

**? Uncertainties:**
- Comprehensive molecular profiling pending; however, it is not a stated criterion in exclusion criteria

**Assessment:**
> The patient's cancer type matches the trial studying synovial sarcoma, and the patient is treatment-naive, meeting the inclusion criteria effectively. All other relevant eligibility factors are satisfied, resulting in a high likelihood of match.

---

### [NCT05227326](https://clinicaltrials.gov/study/NCT05227326)

**First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors**

- **Sponsor**: City of Hope Medical Center
- **Phase**: Phase 1
- **Status**: Recruiting
- **Confidence**: 85%

**‚úì Supporting Factors:**
- Patient has synovial sarcoma, which is included in the trial conditions.
- Patient is treatment-naive with no prior systemic therapy.
- Patient's ECOG status is 0.
- Patient is 28 years old, which meets the age requirement of ‚â• 18 years.

**? Uncertainties:**
- Lab values for ANC, platelet counts, liver function tests (AST, ALT, bilirubin), and creatinine clearance are not provided.

**Assessment:**
> The patient's disease type matches the trial indication for synovial sarcoma, and she is treatment-naive which aligns with the trial requirements. Age and ECOG status also meet the criteria. However, organ function lab values are not available, leading to some uncertainty.

---

## Excluded (98 trials)

### Excluded by Fast Filter

| NCT ID | Reason |
|--------|--------|
| [NCT04256018](https://clinicaltrials.gov/study/NCT04256018) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04390737](https://clinicaltrials.gov/study/NCT04390737) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04771130](https://clinicaltrials.gov/study/NCT04771130) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04797767](https://clinicaltrials.gov/study/NCT04797767) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04858256](https://clinicaltrials.gov/study/NCT04858256) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04889716](https://clinicaltrials.gov/study/NCT04889716) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04890093](https://clinicaltrials.gov/study/NCT04890093) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04901702](https://clinicaltrials.gov/study/NCT04901702) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT04939610](https://clinicaltrials.gov/study/NCT04939610) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05235165](https://clinicaltrials.gov/study/NCT05235165) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05417594](https://clinicaltrials.gov/study/NCT05417594) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05429632](https://clinicaltrials.gov/study/NCT05429632) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05588648](https://clinicaltrials.gov/study/NCT05588648) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05642455](https://clinicaltrials.gov/study/NCT05642455) | Patient age 28 is above maximum age 21 |
| [NCT05730036](https://clinicaltrials.gov/study/NCT05730036) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05853575](https://clinicaltrials.gov/study/NCT05853575) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT05999994](https://clinicaltrials.gov/study/NCT05999994) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT06054555](https://clinicaltrials.gov/study/NCT06054555) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT06056323](https://clinicaltrials.gov/study/NCT06056323) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| [NCT06072131](https://clinicaltrials.gov/study/NCT06072131) | Low relevance score (0.00) - trial doesn't appear to target patient's condition/biomarkers |
| ... | *and 73 more* |

### Excluded by Eligibility Assessment

| NCT ID | Sponsor | Reason |
|--------|---------|--------|
| [NCT06946225](https://clinicaltrials.gov/study/NCT06946225) | Immatics US, Inc. | Patient is treatment-naive, but the trial requires SS participants to have received (or declined) at least one line of treatment. |
| [NCT06083883](https://clinicaltrials.gov/study/NCT06083883) | M.D. Anderson Cancer | Patient has not received any prior systemic therapy, whereas the trial requires patients to have relapsed or refractory disease after at least one prior line of systemic therapy. |
| [NCT06748872](https://clinicaltrials.gov/study/NCT06748872) | Medigene AG | Patient's tumor must have tested positive for NY-ESO-1 and/or LAGE-1a mRNA expression, but this is still pending. |
| [NCT05711615](https://clinicaltrials.gov/study/NCT05711615) | National Cancer Inst | Trial requires patients to have been treated with at least 1 prior line of therapy, while the patient has no prior systemic therapy and is seeking first-line clinical trial options. |
| [NCT05544019](https://clinicaltrials.gov/study/NCT05544019) | Schr√∂dinger, Inc. | Patient has synovial sarcoma (mature B-cell malignancy is not an eligible cancer type) |

## Search Terms Used

| Term | Source | Confidence |
|------|--------|------------|
| SS18-SSX fusion | manual | 1.0 |
| SS18-SSXfusion | manual | 0.9 |
| SS18-SSX-fusion | manual | 0.9 |
| synovial sarcoma | manual | 1.0 |
| SS18-SSX fusion synovial sarcoma | manual | 1.0 |
| SS18-SSX1 fusion synovial sarcoma | llm | 0.9 |
| SS | llm | 0.8 |
| soft tissue sarcoma | llm | 0.8 |
| SS18-SSX1 fusion | llm | 0.9 |
| SS18-SSX1fusion | llm | 0.8 |
| SS18-SSX1-fusion | llm | 0.8 |

## Information That Would Improve Matches

The following patient data was not provided but would help refine eligibility assessment:

- **Organ function labs** (hematology, liver, renal) - required by all interventional trials
